Cardiac 123I-MIBG uptake is affected by variable uptake in reference regions implications for interpretation in clinical studies

Nuclear Medicine Communications

Volumn 17, Issue 10, 1996, Pages 872-876

  Somsen, G Aernout ^a   Schook, M B ^a   Van Royen, E A ^a   Borm, J J J ^a   Dubois, E A ^a   Van Der Wall, E E ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; NORADRENALIN; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; IODOBENZENE; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART SCINTISCANNING; HUMAN; IMAGE ANALYSIS; MALE; RADIOISOTOPE VENTRICULOGRAPHY; AGE; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; HEART; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; REGRESSION ANALYSIS; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

3-IODOBENZYLGUANIDINE; ADULT; AGE FACTORS; AGED; CARDIOMYOPATHIES; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 0029658168     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199610000-00008     Document Type: Article

References (16)

1. Tobes MC, Jacques S Jr, Wieland DM et al. Effect of uptake inhibitors on the uptake of norepinephrine and metaiodo-benzylguanidine. J Nucl Med 1985; 26: 897-907.
2. Mangner TJ, Tobes MC, Wieland DW et al. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma. J Nucl Med 1986; 27: 37-44.
3. Dae MW, O’Connell JW, Botvinick EH et al Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 1989; 79: 634-644.
4. Simmons WW, Freeman MR, Grima EA et al Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]-metaiodobenzylguanidine scintigraphy. Circulation 1994; 89: 2843-2851.
5. Estorch M, Carrio I, Berna L et al. Myocardial iodine-labeled metaiodobenzylguanidine-123 uptake relates to age. J Nucl Cardiol 1995; 2: 126-132.
6. Merlet P, Valette H, Dubois Rande JL et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33: 471-477.
7. Schofer J, Spielmann R, Schuchert A et al. Iodine-123 meta-iodobenzyl-guanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system dis-integrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988; 12: 1252-1258.
8. Merlet P, Pouillart F, Dubois-Rande JL et al. Improved adrenergic nerve function in human failing heart after beta-blocking therapy (abstract). J Nucl Med 1994; 35: 81 P.
9. Somsen GA, Borm JJJ, de Milliano PAR et al. Quantitation of myocardial iodine-123-MIBG uptake in SPECT studies: A new approach using the left ventricular cavity and a blood sample as a reference. Eur J Nucl Med 1995; 22: 1149-1154.
10. Esler MB, Thompson JM, Kaye DM et al. Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. Circulation 1995; 91: 351-358.
11. Merlet P, Dubois Rande J, Adnot S et al. Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 1992; 19: 10-16.
12. Tsuchimochi S, Tamaki N, Tadamura E et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 1995; 36: 969-974.
13. Riggs BL, Wahner HW, Seeman E et al. Changes in bone mineral density of the proximal femur and spine with aging. J Clin Invest 1982; 70: 716-723.
14. Dubois EA, Kam KI, Somsen GA et al. In vitro determination of cardiac sympathetic activation in the presence of hypertension and diabetes mellitus (abstract). Naunyn-Schmiedeberg’s Arch Pharmacol 1995; 351: R141.
15. Degrado TR, Hutchins GD, Toorongian SA et al. Myocardial kinetics of carbon-11-meta-hydroxyephedrine: Retention mechanisms and effects of norepinephrine. J Nucl Med 1993; 34: 1287-1293.
16. Valette H, Loc’h C, Mardon K et al. Bromine-76-meta-bromobenzylguanidine: A PET radiotracer for mapping sympathetic nerves of the heart. J Nucl Med 1993; 34: 1739-1744.